8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2012 / Systematic review and meta-analysis of randomized controlled trials
Researchers analyzed 78 randomized trials examining oral antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, selenium) versus placebo or no intervention. Overall, antioxidant supplements had no significant effect on mortality under a random-effects model (RR 1.02, 95% CI 0.98 to 1.05), but significantly increased mortality in a fixed-effect model (RR 1.03, 95% CI 1.01 to 1.05). In 56 trials with low risk of bias, supplements significantly increased mortality (RR 1.04, 95% CI 1.01 to 1.07), driven by beta-carotene (RR 1.05, 95% CI 1.01 to 1.09) and vitamin E (RR 1.03, 95% CI 1.00 to 1.05). Vitamin A, vitamin C, and selenium did not significantly affect mortality, though higher vitamin A doses were linked to increased mortality in meta-regression (P = 0.002).
Bjelakovic G, Nikolova D, Gluud LL, et al. Cochrane Database Syst Rev, 2012. PMID 22419320
2012 / Meta-analysis of prospective cohorts
A meta-analysis of 7 prospective cohort analyses from 4 articles evaluated 352,384 participants with 13,284 incident type 2 diabetes cases across 4 to 22 years of follow-up. Comparing the highest to lowest intake categories, white rice consumption was associated with diabetes in Asian cohorts (RR 1.55, 95% CI 1.20-2.01) but not significantly in Western cohorts (RR 1.12, 95% CI 0.94-1.33). Each daily serving increase showed an 11% greater risk (RR 1.11, 95% CI 1.08-1.14).
Shows an association, not proof of cause and effect.
Hu EA, Pan A, Malik V, et al. BMJ, 2012. PMID 22422870
2012 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis analyzed randomized controlled trials evaluating soy isoflavones given for 6 weeks to 12 months (median dose 54 mg aglycone equivalents daily). Isoflavone intake reduced hot flash frequency by 20.6% (95% CI -28.38 to -12.86; 13 trials) and severity by 26.2% (95% CI -42.23 to -10.15; 9 trials) compared with placebo. Products providing over 18.8 mg genistein demonstrated greater efficacy.
Taku K, Melby MK, Kronenberg F, et al. Menopause, 2012. PMID 22433977
2012 / Systematic review and meta-analysis of prospective studies
A meta-analysis of 16 prospective studies encompassing 527,441 participants and 24,082 type 2 diabetes cases examined fish and omega-3 intakes. Each additional weekly serving of fish was associated with relative risks of 1.05 (95% CI 1.02-1.09) in U.S. studies, 1.03 (95% CI 0.96-1.11) in European cohorts, and 0.98 (95% CI 0.97-1.00) in Asian/Australian studies. Long-chain n-3 fatty acids showed similar regional divergence.
Shows an association, not proof of cause and effect.
Wallin A, Di Giuseppe D, Orsini N, et al. Diabetes Care, 2012. PMID 22442397
2012 / Meta-analysis and narrative mechanistic review
Researchers conducted a literature search and meta-analysis of data through November 2011 regarding alcohol intake and breast cancer risk, alongside reviewing mechanistic studies. A significant increase of about 4% in breast cancer risk was observed at intakes of up to one alcoholic drink/day, while heavy consumption (three or more drinks/day) was associated with a 40-50% increased risk. Up to 5% of breast cancers in northern Europe and North America (approximately 50,000 cases worldwide) were attributable to alcohol, with up to 1-2% attributable to light drinking alone. Proposed mechanisms included elevated estrogen levels, acetaldehyde, oxidative stress, epigenetic alterations, and decreased retinoic acid concentrations.
Shows an association, not proof of cause and effect.
Seitz HK, Pelucchi C, Bagnardi V, et al. Alcohol Alcohol, 2012. PMID 22459019
2012 / Meta-analysis
Researchers updated a meta-analysis on copper levels in serum, plasma, and cerebrospinal fluid in Alzheimer's disease. The authors excluded four of five previous studies from their laboratory to limit bias and added two newer serum copper investigations. Across the analyzed studies, patients with Alzheimer's disease demonstrated higher copper concentrations than healthy controls.
Ventriglia M, Bucossi S, Panetta V, et al. J Alzheimers Dis, 2012. PMID 22475798
2012 / Systematic review of trials and cohort studies
A systematic review evaluated dietary energy density and body weight using 17 adult studies (7 randomized trials, 1 nonrandomized trial, 9 cohorts) and 6 youth cohorts. Evidence from adult studies indicated that dietary patterns lower in energy density improved weight loss and weight maintenance. In children and adolescents, methodologically rigorous cohort studies found positive associations between dietary energy density and increased adiposity.
Pérez-Escamilla R, Obbagy JE, Altman JM, et al. J Acad Nutr Diet, 2012. PMID 22480489
2012 / Meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 29 randomized controlled trials evaluated the effects of oral vitamin C supplementation (median dose: 500 mg/d; median duration: 8 wk) on blood pressure. Vitamin C supplementation led to pooled reductions of -3.84 mm Hg (95% CI: -5.29, -2.38 mm Hg; P < 0.01) in SBP and -1.48 mm Hg (95% CI: -2.86, -0.10 mm Hg; P = 0.04) in DBP. In hypertensive participants, reductions in SBP and DBP were -4.85 mm Hg (P < 0.01) and -1.67 mm Hg (P = 0.17), respectively. Effects were attenuated but remained significant after including 9 trials with imputed BP effects.
Juraschek SP, Guallar E, Appel LJ, et al. Am J Clin Nutr, 2012. PMID 22492364
2012 / Meta-analysis of randomized controlled trials
A meta-analysis examined 14 double-blind randomized trials enrolling 20,485 individuals with prior cardiovascular conditions. Supplementation with eicosapentaenoic acid and docosahexaenoic acid did not lower overall cardiovascular event risk (RR 0.99; 95% CI, 0.89 to 1.09), heart attacks, strokes, or total mortality. An initial modest reduction in fatal cardiovascular events (RR 0.91; 95% CI, 0.84 to 0.99) disappeared after excluding one trial that had major methodological limitations.
Kwak SM, Myung SK, Lee YJ, et al. Arch Intern Med, 2012. PMID 22493407
2012 / Systematic review and meta-analysis of RCTs and quasi-RCTs
A systematic review identified 8 studies evaluating collagen derivatives (six on collagen hydrolysate [CH], two on gelatine, and one on undenatured collagen [UC]) in osteoarthritis patients. The pooled mean difference across three studies for WOMAC pain reduction comparing CH with placebo was -0.49 (95% CI -1.10 to 0.12), with no significant differences for disability. Gelatine was superior to placebo and alternative therapies for pain, whereas UC showed no significant differences compared to glucosamine plus chondroitin. Adverse events were mostly mild to moderate gastrointestinal complaints, and overall evidence quality was moderate to very low.
Van Vijven JP, Luijsterburg PA, Verhagen AP, et al. Osteoarthritis Cartilage, 2012. PMID 22521757
2012 / Prospective cohort and meta-analysis
In the EPIC-Norfolk cohort (621 incident diabetes cases, 826 non-cases), baseline 25-hydroxyvitamin D was inversely associated with incident type 2 diabetes across quartiles compared to the lowest (highest quartile HR 0.50, 95% CI 0.32-0.76; p trend < 0.001). A meta-analysis of 11 prospective studies encompassing 3,612 cases and 55,713 non-cases reported a combined relative risk of 0.59 (95% CI 0.52-0.67) for highest versus lowest quartiles.
Shows an association, not proof of cause and effect.
Forouhi NG, Ye Z, Rickard AP, et al. Diabetologia, 2012. PMID 22526608
2012 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of randomized controlled trials was conducted to compare the effects of vitamin D2 and vitamin D3 on serum 25(OH)D concentrations in adults. Supplementation with vitamin D3 had a significant positive effect in raising serum 25(OH)D compared with vitamin D2 (P = 0.001). This response was significant when given as a bolus dose (P = 0.0002), though the effect was lost with daily supplementation. The authors noted the review was unable to verify the effects across age, sex, and ethnicity, or the metabolic pathways involved in oral versus intramuscular administration.
Tripkovic L, Lambert H, Hart K, et al. Am J Clin Nutr, 2012. PMID 22552031
2012 / Meta-analysis of prospective cohorts
In a meta-analysis of 18 prospective cohorts including 540,184 people and 25,670 incident diabetes cases, seafood intake was not significantly associated with type 2 diabetes risk (RR per 100 g/day = 1.12, 95% CI = 0.94, 1.34). Similarly, consumption of EPA plus DHA (RR per 250 mg/day = 1.04, 95% CI = 0.97, 1.10) and biomarker levels showed no significant links. Plant-derived alpha-linolenic acid intake showed a non-significant trend toward lower diabetes risk.
Shows an association, not proof of cause and effect.
Wu JH, Micha R, Imamura F, et al. Br J Nutr, 2012. PMID 22591895
2012 / Systematic review
A systematic review of older adults evaluated 25 studies for comorbidity and 17 for mortality. Most evaluated studies relied on anthropometric measures such as BMI, waist circumference, and waist-hip ratio, with relatively few using direct measures like body fat/lean mass. Reported findings were inconsistent regarding the strongest predictor of morbidity and mortality. However, most studies suggested BMI alone was not the most appropriate predictor because it cannot detect age-related body fat redistribution, and studies using BMI found the lowest mortality at overweight (25 kg/m²≤BMI<30 kg/m²) or mildly obese (30 kg/m²≤BMI<35 kg/m²) ranges.
Shows an association, not proof of cause and effect.
Chang SH, Beason TS, Hunleth JM, et al. Maturitas, 2012. PMID 22595204
2012 / Systematic review of randomized controlled trials
A systematic review was conducted across multiple databases to identify RCTs comparing cognitive behavioral therapy for insomnia (CBT-I) to prescription or non-prescription medications. Based on 5 included studies, low to moderate grade evidence suggested CBT-I has superior effectiveness to benzodiazepine and non-benzodiazepine drugs in the long term. Conversely, very low grade evidence suggested benzodiazepines were more effective in the short term, and very low grade evidence supported CBT-I for improving psychological outcomes.
Mitchell MD, Gehrman P, Perlis M, et al. BMC Fam Pract, 2012. PMID 22631616
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of 12 randomized controlled trials involving 1,802 infants evaluated long-chain polyunsaturated fatty acid supplementation in formula. Supplementation showed no significant effect on early cognitive scores measured by the Bayley Scales of Infant Development. Further subgroup analyses showed that neither fatty acid dosage nor infant prematurity status significantly altered cognitive outcomes.
Qawasmi A, Landeros-Weisenberger A, Leckman JF, et al. Pediatrics, 2012. PMID 22641753
2012 / Systematic review and meta-analysis of prospective cohorts and RCTs
Researchers systematically evaluated 45 prospective cohort studies and 21 RCTs investigating whole-grain and fiber intake. In prospective cohorts, consuming 48-80 g/d (3-5 servings/d) compared with never/rare intake was associated with lower risk of type 2 diabetes (RR = 0.74, 95% CI: 0.69, 0.80), lower risk of CVD (RR = 0.79, 95% CI: 0.74, 0.85), and less weight gain over 8-13 years (1.27 vs 1.64 kg; P = 0.001). In RCTs, whole-grain interventions significantly reduced post-intervention fasting glucose (-0.93 mmol/L, 95% CI: -1.65, -0.21), total cholesterol (-0.83 mmol/L, 95% CI: -1.23, -0.42), and LDL cholesterol (-0.82 mmol/L, 95% CI: -1.31, -0.33).
Ye EQ, Chacko SA, Chou EL, et al. J Nutr, 2012. PMID 22649266
2012 / Systematic review
A systematic review of 22 studies evaluated adult diabetes trends in mainland China from 2000 to 2010. Diabetes prevalence increased nationally from 2.6% to 9.7% over the decade. The condition was strongly associated with older age and was more prevalent in urban than rural populations, with common reported links to obesity, family history, and hypertension.
Li H, Oldenburg B, Chamberlain C, et al. Diabetes Res Clin Pract, 2012. PMID 22658670
2012 / Meta-analysis of randomized controlled trials and cohort studies
A meta-analysis examined whether intake of fish, fish oil, or long-chain omega-3 fatty acids influenced new-onset or recurrent atrial fibrillation. Across 11 randomized controlled trials, omega-3 fatty acids did not significantly reduce atrial fibrillation risk (OR=0.79; 95% CI, 0.56-1.12; p=0.19). Similarly, in seven cohort studies, exposure was not significantly associated with atrial fibrillation incidence (OR=0.83; 95% CI, 0.59-1.16; p=0.27).
Khawaja O, Gaziano JM, Djoussé L J Am Coll Nutr, 2012. PMID 22661621
2012 / Meta-analysis of prospective cohorts
A meta-analysis analyzed data from seven prospective cohort studies covering 124,706 participants from multiple countries. Vegetarian diets were associated with a significantly lower risk of ischemic heart disease mortality (RR = 0.71; 95% CI, 0.56-0.87) and lower overall cancer incidence (RR = 0.82; 95% CI, 0.67-0.97). Differences were not statistically significant for all-cause mortality (RR = 0.91; 95% CI, 0.66-1.16), circulatory disease mortality (RR = 0.84; 95% CI, 0.54-1.14), or cerebrovascular mortality (RR = 0.88; 95% CI, 0.70-1.06).
Shows an association, not proof of cause and effect.
Huang T, Yang B, Zheng J, et al. Ann Nutr Metab, 2012. PMID 22677895
2012 / Systematic review
Researchers systematically reviewed studies that monitored compliance to exercise prescriptions and measured exercise-induced changes in body composition. Changes in body energy stores were calculated to determine deficits between total daily energy intake and energy expenditures to evaluate reasons for low exercise-induced weight loss. The review concluded that the small magnitude of weight loss seen in most evaluated interventions is mainly due to low doses of prescribed exercise energy expenditures combined with a concomitant increase in caloric intake.
Thomas DM, Bouchard C, Church T, et al. Obes Rev, 2012. PMID 22681398
2012 / Systematic review and meta-analysis of randomized controlled trials
Three randomized controlled trials evaluated omega-3 fatty acid supplementation for 6 to 40 months in healthy adults aged 60 and older. In two trials with 3,221 participants, Mini-Mental State Examination scores did not differ between omega-3 and placebo groups (MD -0.07, 95% CI -0.25 to 0.10). Tests of word learning, digit span, and verbal fluency in 1,043 participants also showed no benefits, and incident dementia was not evaluated.
Sydenham E, Dangour AD, Lim WS Cochrane Database Syst Rev, 2012. PMID 22696350
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of five randomized trials examined Ganoderma lucidum in cancer care. Combining the mushroom with chemotherapy or radiotherapy increased the likelihood of a positive response compared to conventional therapy alone (RR 1.50, 95% CI 0.90 to 2.51). Furthermore, supplementation raised CD3, CD4, and CD8 percentages by 3.91%, 3.05%, and 2.02%, while quality of life was relatively improved in four studies.
Jin X, Ruiz Beguerie J, Sze DM, et al. Cochrane Database Syst Rev, 2012. PMID 22696372
2012 / Systematic review and meta-analysis of prospective cohorts
A systematic review and meta-analysis examined prospective studies evaluating combined lifestyle behaviors including diet, physical activity, smoking, alcohol, and obesity. Across 15 studies with 531,804 individuals followed for an average of 13.24 years, adhering to at least four healthy lifestyle factors was linked to a 66% lower risk of all-cause mortality (95% CI 58% to 73%) compared to having the fewest healthy factors.
Shows an association, not proof of cause and effect.
Loef M, Walach H Prev Med, 2012. PMID 22735042